Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6851
CALL
Walker & Dunlop
WD
$1.46B
| $513K | ﹤0.01% |
10,100
+4,500
| +80% | +$184K |
|
6852
CALL
Regenxbio
RGNX
$711M
| $512K | ﹤0.01% |
13,900
-22,500
| -62% | -$839K |
|
|
STLV
6853
DELISTED
iShares Factors US Value Style ETF
STLV
| $512K | ﹤0.01% |
+25,243
| New | +$492K |
|
6854
PUT
Rogers Corp
ROG
$2.55B
| $511K | ﹤0.01% |
4,100
-4,000
| -49% | -$428K |
|
6855
WBI BullBear Quality 3000 ETF
WBIL
$31.1M
| $511K | ﹤0.01% |
19,612
+1,000
| +5% | +$25.8K |
|
6856
PUT
Itron
ITRI
$4.45B
| $510K | ﹤0.01% |
7,700
-6,600
| -46% | -$420K |
|
6857
ProShares Pet Care ETF
PAWZ
$33.8M
| $510K | ﹤0.01% |
+10,321
| New | +$467K |
|
6858
CALL
RCI Hospitality Holdings
RICK
$236M
| $510K | ﹤0.01% |
36,800
+6,100
| +20% | +$74.5K |
|
|
TVRD
6859
Tvardi Therapeutics
TVRD
$25.3M
| $510K | ﹤0.01% |
+828
| New | +$457K |
|
6860
PUT
Malibu Boats
MBUU
$576M
| $509K | ﹤0.01% |
+9,800
| New | +$392K |
|
6861
CALL
UBS Group
UBS
$176B
| $509K | ﹤0.01% |
44,100
+32,300
| +274% | +$333K |
|
6862
Invesco RAFI Strategic US ETF
IUS
$958M
| $508K | ﹤0.01% |
20,102
+10,610
| +112% | +$256K |
|
6863
MannKind Corp
MNKD
$1.24B
| $508K | ﹤0.01% |
290,370
+171,383
| +144% | +$239K |
|
|
THS
6864
CALL
DELISTED
Treehouse Foods
THS
| $508K | ﹤0.01% |
11,600
+1,500
| +15% | +$73.2K |
|
|
FSKR
6865
DELISTED
FS KKR Capital Corp. II
FSKR
| $508K | ﹤0.01% |
+39,391
| New | +$520K |
|
|
EQC.PRD
6866
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $508K | ﹤0.01% |
18,310
| – | – |
|
6867
PUT
Armstrong World Industries
AWI
$7.7B
| $507K | ﹤0.01% |
6,500
+3,800
| +141% | +$288K |
|
6868
Cardlytics
CDLX
$24.9M
| $507K | ﹤0.01% |
725
-8,773
| -92% | -$5.07M |
|
|
DENN
6869
CALL
DELISTED
Denny's
DENN
| $507K | ﹤0.01% |
+50,200
| New | +$515K |
|
6870
PUT
Lands' End
LE
$384M
| $507K | ﹤0.01% |
63,000
-5,400
| -8% | -$38.8K |
|
6871
PUT
NNN REIT
NNN
$8.83B
| $507K | ﹤0.01% |
14,300
+6,700
| +88% | +$219K |
|
6872
PUT
NETGEAR
NTGR
$656M
| $507K | ﹤0.01% |
19,600
+3,900
| +25% | +$94.9K |
|
|
TEN
6873
PUT
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $507K | ﹤0.01% |
67,100
-18,900
| -22% | -$110K |
|
|
APLS
6874
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $506K | ﹤0.01% |
15,500
+3,600
| +30% | +$116K |
|
6875
PUT
Core Laboratories
CLB
$571M
| $506K | ﹤0.01% |
24,900
+6,800
| +38% | +$122K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.